CDC, FDA Investigate Counterfeit Botox Linked to Illnesses in Nine States

Federal agencies are addressing a series of harmful reactions caused by counterfeit Botox injections, stressing the importance of receiving treatments from licensed professionals.

19 individuals across nine states have reported adverse effects after receiving counterfeit or improperly administered Botox injections.
Symptoms include vision problems, muscle weakness, and difficulty breathing, with some cases requiring hospitalization.
The FDA has issued alerts and is working with Botox manufacturer AbbVie to trace and remove counterfeit products.
Health authorities urge the public to verify the licensure of providers and the FDA approval of Botox products before undergoing treatment.
No deaths have been reported, but the situation highlights risks associated with non-medical administration of botulinum toxin.